The pharma industry claims lower prescription drug prices will mean less access to new medication for Canadians. It’s an old threat that pits profits against patients’ rights to affordable drugs.
Academic rigor, journalistic flair
Articles on Pharma industry
Displaying all articles
The Purdue Pharma settlement is paltry compared to costs of the opioid crisis. Without major changes to pharma industry regulation, there is little reason to think a similar crisis won’t occur again.
Voluntary medical societies have important roles in professional education and advocacy for doctors and patients, but there is need for transparency about relationships with pharma and health industry.
The U.S. FDA has approved the first COVID-19 vaccine. How is approval different from emergency use authorization, and what difference will it make to a vaccine that’s already in global use?
Why are so many entrepreneurs in Canada avoiding going public, and what are the consequences for our economy?
Top contributors
-
Professor Emeritus of Health Policy and Management, York University, Canada
-
Professor of medicine, epidemiology & biostatistics, and philosophy, Western University
-
Associate Professor of Finance, University of Calgary
-
N. Murray Edwards Chair in Business Law, University of Calgary
-
PhD Candidate, Dalla Lana School of Public Health, University of Toronto
